BIOCHEMFUSION ApS: Financial statements 2024
CVR: 32057446
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BIOCHEMFUSION ApS (CVR 32057446) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 682,776 and a net result of DKK -4,593 compared with DKK 83,203 the year before. That is a decrease of 17.1% compared with the year before. Equity in the 2024 report amounted to DKK 281,071. The solvency ratio was 73%.
- Gross Profit
- DKK 682,776
- Profit/Loss
- DKK -4,593
- Equity
- DKK 281,071
- Total Assets
- DKK 385,146
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 683 t. | -5 t. | 281 t. | - |
| 2023 | - | 824 t. | 83 t. | 361 t. | - |
| 2022 | - | 713 t. | -13 t. | 277 t. | - |
| 2021 | - | 946 t. | 190 t. | 440 t. | - |
| 2020 | - | 832 t. | 116 t. | 400 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BIOCHEMFUSION ApS has published its annual report for 2023. Gross profit came to DKK 823,937, and the net result was DKK 83,203.
About BIOCHEMFUSION ApS
BIOCHEMFUSION ApS is a Danish company of the type Anpartsselskab based in Ølsted, founded in 2009. The company is registered under the industry Anden udgivelse af software. The management consists of Jan Holst Jensen. The company is owned by BIOCHEMFUSION HOLDING ApS. In 2025, the company reported a gross profit of DKK 1,156,041 and a net result of DKK 194,096 compared with DKK -4,593 the year before. Equity in the 2025 report amounted to DKK 475,167.